Biomarker research

Keyphrases

Publications

volume 11, number 1, 2023

Sihui Li, Shizhen Shen, Wanzhong Ge, Yixuan Cen, Songfa Zhang, Xiaodong Cheng, Xinyu Wang, Xing Xie, Weiguo Lu
Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation. Biomarker research 11 (1) (2023)
Luis A Godoy, Joy Chen, Weijie Ma, Jag Lally, Kyra A Toomey, Prabhu Rajappa, Roya Sheridan, Shirish Mahajan, Nicholas Stollenwerk, Chinh T Phan, Danny Cheng, Robert J Knebel, Tianhong Li
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives. Biomarker research 11 (1) (2023)
Yvyin Zhang, Peihong Wang, Yang Wang, Yang Shen
Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia. Biomarker research 11 (1) (2023)
Shuangli Zhu, Wanling Li, Hao Zhang, Yuheng Yan, Qi Mei, Kongming Wu
Retinal determination gene networks: from biological functions to therapeutic strategies. Biomarker research 11 (1) (2023)
Yuting Xue, Xuejiao Jiang, Junrong Wang, Yuxuan Zong, Zhennan Yuan, Susheng Miao, Xionghui Mao
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomarker research 11 (1) (2023)
Fanqin Bu, Xiangji Li, Yu Zhao, Liyi Bai, Shutian Zhang, Li Min
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes. Biomarker research 11 (1) (2023)
Ying Zhang, Hui-Hui Hu, Shi-Hong Zhou, Wu-Yan Xia, Yan Zhang, Jian-Ping Zhang, Xiao-Long Fu, Wen Yu
PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer. Biomarker research 11 (1) (2023)
Yvyin Zhang, Peihong Wang, Yang Wang, Yang Shen
Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia. Biomarker research 11 (1) (2023)
Abderrahim Oussalah, Jonas Callet, Anne-Elisabeth Manteaux, Nathalie Thilly, Nicolas Jay, Jean-Louis Guéant, Alain Lozniewski
Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study. Biomarker research 11 (1) (2023)
Abderrahim Oussalah, Jonas Callet, Anne-Elisabeth Manteaux, Nathalie Thilly, Nicolas Jay, Jean-Louis Guéant, Alain Lozniewski
Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study. Biomarker research 11 (1) (2023)
Shuangli Zhu, Wanling Li, Hao Zhang, Yuheng Yan, Qi Mei, Kongming Wu
Retinal determination gene networks: from biological functions to therapeutic strategies. Biomarker research 11 (1) (2023)
Qing Zhu, Yixuan Zhang, Mo Li, Ying Zhang, Huan Zhang, Jiayi Chen, Zhaoyang Liu, Peng Yuan, Zhaogang Yang, Xiaobing Wang
MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling. Biomarker research 11 (1) (2023)
Jie Zha, Qinwei Chen, Jingjing Ye, Haifeng Yu, Shuhua Yi, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Caixia Li, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Liyuan Fan, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study. Biomarker research 11 (1) (2023)
Kiersten Campbell, Niamh X Cawley, Rachel Luke, Katelin E J Scott, Nicholas Johnson, Nicole Y Farhat, Derek Alexander, Christopher A Wassif, Wenping Li, Stephanie M Cologna, Elizabeth Berry-Kravis, An Dang Do, Ryan K Dale, Forbes D Porter
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. Biomarker research 11 (1) (2023)
Jie Zha, Qinwei Chen, Jingjing Ye, Haifeng Yu, Shuhua Yi, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Caixia Li, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Liyuan Fan, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study. Biomarker research 11 (1) (2023)
Ying Zhang, Hui-Hui Hu, Shi-Hong Zhou, Wu-Yan Xia, Yan Zhang, Jian-Ping Zhang, Xiao-Long Fu, Wen Yu
PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer. Biomarker research 11 (1) (2023)
Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses. Biomarker research 11 (1) (2023)
Ying Zhang, Hui-Hui Hu, Shi-Hong Zhou, Wu-Yan Xia, Yan Zhang, Jian-Ping Zhang, Xiao-Long Fu, Wen Yu
PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer. Biomarker research 11 (1) (2023)
Kiersten Campbell, Niamh X Cawley, Rachel Luke, Katelin E J Scott, Nicholas Johnson, Nicole Y Farhat, Derek Alexander, Christopher A Wassif, Wenping Li, Stephanie M Cologna, Elizabeth Berry-Kravis, An Dang Do, Ryan K Dale, Forbes D Porter
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. Biomarker research 11 (1) (2023)
Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. Biomarker research 11 (1) (2023)
Abderrahim Oussalah, Jonas Callet, Anne-Elisabeth Manteaux, Nathalie Thilly, Nicolas Jay, Jean-Louis Guéant, Alain Lozniewski
Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study. Biomarker research 11 (1) (2023)
Jianye Tan, Bingsheng Yang, Haobo Zhong, Mengliang Luo, Zexin Su, Chao Xie, Meiling Shi, Chunhan Sun, Lijun Lin
Circular RNA circEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression. Biomarker research 11 (1) (2023)
Wenjun Ren, Yixiao Yuan, Yongwu Li, Luciano Mutti, Jun Peng, Xiulin Jiang
The function and clinical implication of YTHDF1 in the human system development and cancer. Biomarker research 11 (1) (2023)
Yuting Xue, Xuejiao Jiang, Junrong Wang, Yuxuan Zong, Zhennan Yuan, Susheng Miao, Xionghui Mao
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomarker research 11 (1) (2023)
Jianye Tan, Bingsheng Yang, Haobo Zhong, Mengliang Luo, Zexin Su, Chao Xie, Meiling Shi, Chunhan Sun, Lijun Lin
Circular RNA circEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression. Biomarker research 11 (1) (2023)
Yalan Deng, Liqing Lu, Huajun Zhang, Ying Fu, Ting Liu, Yongheng Chen
The role and regulation of Maf proteins in cancer. Biomarker research 11 (1) (2023)
Yuting Xue, Xuejiao Jiang, Junrong Wang, Yuxuan Zong, Zhennan Yuan, Susheng Miao, Xionghui Mao
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomarker research 11 (1) (2023)
Hai-Ping Dai, Dan-Qing Kong, Hong-Jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-Qing Kang, Lei Yu, De-Pei Wu, Xiao-Wen Tang
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL. Biomarker research 11 (1) (2023)
Yalan Deng, Liqing Lu, Huajun Zhang, Ying Fu, Ting Liu, Yongheng Chen
The role and regulation of Maf proteins in cancer. Biomarker research 11 (1) (2023)
Hai-Ping Dai, Dan-Qing Kong, Hong-Jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-Qing Kang, Lei Yu, De-Pei Wu, Xiao-Wen Tang
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL. Biomarker research 11 (1) (2023)
Hua Yang, Yang Xun, Hua You
The landscape overview of CD47-based immunotherapy for hematological malignancies. Biomarker research 11 (1) (2023)
Hua Yang, Yang Xun, Hua You
The landscape overview of CD47-based immunotherapy for hematological malignancies. Biomarker research 11 (1) (2023)
Hua Yang, Yang Xun, Hua You
The landscape overview of CD47-based immunotherapy for hematological malignancies. Biomarker research 11 (1) (2023)
Guiyan Yang, Prasant K Jena, Ying Hu, Lili Sheng, Shin-Yu Chen, Carolyn M Slupsky, Ryan Davis, Clifford G Tepper, Yu-Jui Yvonne Wan
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study. Biomarker research 11 (1) (2023)
Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses. Biomarker research 11 (1) (2023)
Sihui Li, Shizhen Shen, Wanzhong Ge, Yixuan Cen, Songfa Zhang, Xiaodong Cheng, Xinyu Wang, Xing Xie, Weiguo Lu
Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation. Biomarker research 11 (1) (2023)
Qian Liu, Pingzhao Hu
Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer. Biomarker research 11 (1) (2023)
Fanqin Bu, Xiangji Li, Yu Zhao, Liyi Bai, Shutian Zhang, Li Min
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes. Biomarker research 11 (1) (2023)
Qian Liu, Pingzhao Hu
Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer. Biomarker research 11 (1) (2023)
Yungchang Chen, Hao Sun, Yanhong Deng, Yutong Ma, He Huang, Yang Liu, Yaru Zhang, Hongyu Zhang, Sheng Ye, Mingyan E, Hongqiang Guo, Mengmeng Wu, Chunman Wu, Xingxiang Pu, Xinggui Chen, Chaoyong Liang, Qiuxiang Ou, Huawei Weng, Xue Wu, Yang Shao, Anxin Gu, Tongyu Lin
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses. Biomarker research 11 (1) (2023)
Yvyin Zhang, Peihong Wang, Yang Wang, Yang Shen
Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia. Biomarker research 11 (1) (2023)
Xiuwen Guan, Fei Ma, Qiao Li, Shanshan Chen, Bo Lan, Ying Fan, Jiayu Wang, Yang Luo, Ruigang Cai, Pin Zhang, Qing Li, Binghe Xu
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies. Biomarker research 11 (1) (2023)
Wenjun Ren, Yixiao Yuan, Yongwu Li, Luciano Mutti, Jun Peng, Xiulin Jiang
The function and clinical implication of YTHDF1 in the human system development and cancer. Biomarker research 11 (1) (2023)
Luis A Godoy, Joy Chen, Weijie Ma, Jag Lally, Kyra A Toomey, Prabhu Rajappa, Roya Sheridan, Shirish Mahajan, Nicholas Stollenwerk, Chinh T Phan, Danny Cheng, Robert J Knebel, Tianhong Li
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives. Biomarker research 11 (1) (2023)
Xiuwen Guan, Fei Ma, Qiao Li, Shanshan Chen, Bo Lan, Ying Fan, Jiayu Wang, Yang Luo, Ruigang Cai, Pin Zhang, Qing Li, Binghe Xu
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies. Biomarker research 11 (1) (2023)
Guiyan Yang, Prasant K Jena, Ying Hu, Lili Sheng, Shin-Yu Chen, Carolyn M Slupsky, Ryan Davis, Clifford G Tepper, Yu-Jui Yvonne Wan
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study. Biomarker research 11 (1) (2023)
Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. Biomarker research 11 (1) (2023)
Jianye Tan, Bingsheng Yang, Haobo Zhong, Mengliang Luo, Zexin Su, Chao Xie, Meiling Shi, Chunhan Sun, Lijun Lin
Circular RNA circEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression. Biomarker research 11 (1) (2023)
Yuting Xue, Xuejiao Jiang, Junrong Wang, Yuxuan Zong, Zhennan Yuan, Susheng Miao, Xionghui Mao
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomarker research 11 (1) (2023)
Qing Zhu, Yixuan Zhang, Mo Li, Ying Zhang, Huan Zhang, Jiayi Chen, Zhaoyang Liu, Peng Yuan, Zhaogang Yang, Xiaobing Wang
MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling. Biomarker research 11 (1) (2023)